thyroxine has been researched along with Hyperpigmentation in 7 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Hyperpigmentation: Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Type 1 diabetes mellitus had been diagnosed when he was 13 years old, hypothyroidism was treated with L-thyroxine for 2 years." | 3.72 | [Prerenal kidney failure in type 1 diabetes mellitus]. ( Hübinger, A; Scherbaum, WA; Schloot, NC, 2003) |
| " Both Addison disease and Hashimoto thyroiditis were then confirmed by elevated serum levels of ACTH, TSH, and decreased levels of cortisol and L-thyroxine." | 3.71 | [Increasing pigmentation in Schmidt syndrome (polyglandular autoimmune syndrome type II]. ( Gärtner, R; Hesse, G; Sünkel, S; Wichmann-Hesse, A, 2001) |
| "Differentiated thyroid cancers (DTCs) present mainly as sporadic, but they may have also a familial component." | 1.35 | Differentiated thyroid carcinoma (DTC) in a young woman with Peutz-Jeghers syndrome: are these two conditions associated? ( Benatti, P; Carani, C; Diazzi, C; Ponz De Leon, M; Rochira, V; Romano, S; Roncucci, L; Rossi, G; Zirilli, L, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Glick, A | 1 |
| Sista, V | 1 |
| Johnson, C | 1 |
| Ho, V | 1 |
| Banney, L | 1 |
| Falhammar, H | 1 |
| Zirilli, L | 1 |
| Benatti, P | 1 |
| Romano, S | 1 |
| Roncucci, L | 1 |
| Rossi, G | 1 |
| Diazzi, C | 1 |
| Carani, C | 1 |
| Ponz De Leon, M | 1 |
| Rochira, V | 1 |
| ARAKAWA, T | 1 |
| WADA, Y | 1 |
| TADA, K | 1 |
| ITO, H | 1 |
| Schloot, NC | 1 |
| Hübinger, A | 1 |
| Scherbaum, WA | 1 |
| Kasraee, B | 1 |
| Handjani, F | 1 |
| Parhizgar, A | 1 |
| Omrani, GR | 1 |
| Fallahi, MR | 1 |
| Amini, M | 1 |
| Nikbakhsh, M | 1 |
| Tran, C | 1 |
| Hügin, A | 1 |
| Sorg, O | 1 |
| Saurat, JH | 1 |
| Sünkel, S | 1 |
| Wichmann-Hesse, A | 1 |
| Gärtner, R | 1 |
| Hesse, G | 1 |
7 other studies available for thyroxine and Hyperpigmentation
| Article | Year |
|---|---|
Oral Manifestations of Commonly Prescribed Drugs.
Topics: Albuterol; Amlodipine; Anticonvulsants; Antihypertensive Agents; Atorvastatin; Bisphosphonate-Associ | 2020 |
Hyperpigmentation, nail dystrophy and alopecia with generalised intestinal polyposis: Cronkhite-Canada syndrome.
Topics: Alopecia; Female; Goiter, Nodular; Humans; Hyperpigmentation; Intestinal Polyposis; Middle Aged; Nai | 2008 |
Differentiated thyroid carcinoma (DTC) in a young woman with Peutz-Jeghers syndrome: are these two conditions associated?
Topics: Adult; Female; Humans; Hyperpigmentation; Intestinal Obstruction; Peutz-Jeghers Syndrome; Thyroid Ne | 2009 |
HYPERPIGMENTATION OF THE SKIN WITH DOPA-URIA OF A NEWBORN. (A PECULIAR SIGN OF AN INFANT BORN OF A THYROTOXIC MOTHER TREATED WITH METHIMAZOL).
Topics: Antithyroid Agents; Dihydroxyphenylalanine; Female; Humans; Hyperpigmentation; Infant; Infant, Newbo | 1963 |
[Prerenal kidney failure in type 1 diabetes mellitus].
Topics: Addison Disease; Adult; Anti-Inflammatory Agents; Diabetes Mellitus, Type 1; Diagnosis, Differential | 2003 |
Topical methimazole as a new treatment for postinflammatory hyperpigmentation: report of the first case.
Topics: Administration, Cutaneous; Adult; Burns, Chemical; Dermatologic Agents; Facial Dermatoses; Humans; H | 2005 |
[Increasing pigmentation in Schmidt syndrome (polyglandular autoimmune syndrome type II].
Topics: Addison Disease; Adolescent; Anti-Inflammatory Agents; Biopsy; Drug Therapy, Combination; Fludrocort | 2001 |